ARID1A/BAF250a as a prognostic marker for gastric carcinoma: a study of 2 cohorts.

[1]  M. Sawabe,et al.  Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach , 2013, Gastric Cancer.

[2]  H. Yoshiyama,et al.  Epstein-Barr Virus (EBV)-associated Gastric Carcinoma , 2012, Viruses.

[3]  S. Ishikawa,et al.  ARID1A expression loss in gastric cancer: pathway-dependent roles with and without Epstein–Barr virus infection and microsatellite instability , 2012, Virchows Archiv.

[4]  K. Pan,et al.  Decreased Expression of the ARID1A Gene Is Associated with Poor Prognosis in Primary Gastric Cancer , 2012, PloS one.

[5]  Bin Tean Teh,et al.  Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes , 2012, Nature Genetics.

[6]  J. T. Jørgensen,et al.  HER2 as a Prognostic Marker in Gastric Cancer - A Systematic Analysis of Data from the Literature , 2012, Journal of Cancer.

[7]  Zhengyan Kan,et al.  Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer , 2011, Nature Genetics.

[8]  Meng Li,et al.  Somatic Mutations in the Chromatin Remodeling Gene ARID1A Occur in Several Tumor Types , 2011, Human mutation.

[9]  S. Wiseman,et al.  Loss of BAF250a (ARID1A) is frequent in high‐grade endometrial carcinomas , 2011, The Journal of pathology.

[10]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[11]  Richard A. Moore,et al.  ARID1A mutations in endometriosis-associated ovarian carcinomas. , 2010, The New England journal of medicine.

[12]  Matt van de Rijn,et al.  Identification of prognostically relevant and reproducible subsets of endometrial adenocarcinoma based on clustering analysis of immunostaining data , 2007, Modern Pathology.

[13]  S. Spechler,et al.  Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach , 2005, CA: a cancer journal for clinicians.

[14]  H. Lee,et al.  Clinicopathologic and protein expression differences between cardia carcinoma and noncardia carcinoma of the stomach , 2005, Cancer.

[15]  H. Lee,et al.  Distinct Clinical Features and Outcomes of Gastric Cancers with Microsatellite Instability , 2002, Modern Pathology.

[16]  R. Kingston,et al.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. , 2001, Genes & development.

[17]  G. Crabtree,et al.  Diversity and specialization of mammalian SWI/SNF complexes. , 1996, Genes & development.

[18]  C. Roberts,et al.  ARID1A mutations in cancer: another epigenetic tumor suppressor? , 2013, Cancer discovery.

[19]  C. Compton,et al.  AJCC Cancer Staging Manual , 2002, Springer New York.